Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash flows from operating activities
Net income (loss)	$ 890.9	$ (709.0)
Adjustments to reconcile net income (loss) to net cash flows from operating activities:
Depreciation and amortization	13.4	12.6
Equity-based compensation	32.4	29.1
Non-cash performance allocations and incentive fees	(865.4)	550.5
Non-cash principal investment (income) loss	(176.2)	252.1
Other non-cash amounts	8.5	(9.5)
Consolidated Funds related:
Realized/unrealized (gain) loss on investments of Consolidated Funds	(89.3)	932.7
Realized/unrealized (gain) loss from loans payable of Consolidated Funds	77.0	(819.6)
Purchases of investments by Consolidated Funds	(925.5)	(807.5)
Proceeds from sale and settlements of investments by Consolidated Funds	1,074.1	327.2
Non-cash interest income, net	(3.2)	(1.2)
Change in cash and cash equivalents held at Consolidated Funds	(30.9)	(51.4)
Change in other receivables held at Consolidated Funds	(84.3)	(15.9)
Change in other liabilities held at Consolidated Funds	(7.3)	162.3
Other non-cash amounts of Consolidated Funds	0.0	(0.2)
Purchases of investments	(63.8)	(42.7)
Proceeds from the sale of investments	156.0	99.8
Payments of contingent consideration	(49.9)	0.0
Changes in deferred taxes, net	260.3	(101.0)
Change in due from affiliates and other receivables	(6.8)	11.1
Change in deposits and other	(1.4)	(2.1)
Change in accounts payable, accrued expenses and other liabilities	(69.1)	(54.0)
Change in accrued compensation and benefits	(328.0)	(196.6)
Change in due to affiliates	(0.4)	(35.2)
Change in lease right-of-use assets and lease liabilities	2.6	(3.3)
Change in deferred revenue	255.8	225.9
Net cash provided by (used in) operating activities	69.5	(245.9)
Cash flows from investing activities
Purchases of fixed assets, net	(9.7)	(13.2)
Net cash used in investing activities	(9.7)	(13.2)
Cash flows from financing activities
Borrowings under credit facilities	0.0	251.0
Repayments under credit facilities	0.0	(35.8)
Payments on debt obligations	(66.6)	(0.3)
Proceeds from debt obligations, net of financing costs	43.4	0.0
Net borrowings (payments) on loans payable of Consolidated Funds	(20.0)	393.3
Dividends to common stockholders	(88.7)	(87.4)
Payment of deferred consideration for Carlyle Holdings units	(68.8)	(68.8)
Contributions from non-controlling interest holders	3.7	4.2
Distributions to non-controlling interest holders	(15.3)	(24.3)
Common shares repurchased	(10.0)	(26.4)
Change in due to/from affiliates financing activities	71.1	51.1
Change in due to/from affiliates and other receivables of Consolidated Funds	0.0	0.0
Net cash provided by (used in) financing activities	(151.2)	456.6
Effect of foreign exchange rate changes	(11.2)	(17.0)
Increase (decrease) in cash, cash equivalents and restricted cash	(102.6)	180.5
Cash, cash equivalents and restricted cash, beginning of period	989.6	828.0
Cash, cash equivalents and restricted cash, end of period	887.0	1,008.5
Supplemental non-cash disclosures
Tax effects from the conversion to a Corporation recorded in equity	0.0	53.6
Reconciliation of cash, cash equivalents and restricted cash, end of period:
Total cash, cash equivalents and restricted cash, end of period	$ 887.0	$ 1,008.5